Reaction
Deafness Transitory reporting signals
As of the last recalculation, Deafness Transitory appears in 846 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is DICLOFENAC POTASSIUM, FILM COATED (PRR 305.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Diclofenac Potassium, Film Coated | 93 | 305.4 | 308.8 |
| Diclofenac Potassium Tablets | 93 | 305.1 | 308.6 |
| Diclofenac Potassium | 93 | 237.8 | 239.8 |
| Ibuprofen And Diphenhydramine Citrate | 145 | 184.8 | 185.9 |
| Leflunomide | 194 | 58.9 | 59.0 |
| Diclofenac | 152 | 52.7 | 52.8 |
| Trimethoprim | 24 | 51.5 | 51.6 |
| Tramadol Hydrochloride | 72 | 51.3 | 51.4 |
| Hydroxychloroquine Sulfate | 135 | 43.2 | 43.3 |
| Hydroxychloroquine | 96 | 35.6 | 35.6 |
| Diclofenac Sodium | 161 | 32.3 | 32.3 |
| Ascorbic Acid | 25 | 27.2 | 27.2 |
| Naproxen | 75 | 25.7 | 25.7 |
| Diclofenac Sodium 1% | 34 | 24.4 | 24.4 |
| Diclofenac Sodium Topical | 34 | 24.4 | 24.4 |
| Diclofenac Sodium Topical Gel, 1% | 34 | 24.3 | 24.3 |
| Primidone | 9 | 22.0 | 22.0 |
| Ibuprofen | 187 | 21.5 | 21.5 |
| Naproxen Sodium Tablet, Coated | 11 | 20.2 | 20.3 |
| Naproxen Sodium, Coated Tablets | 11 | 20.2 | 20.3 |
| Naproxen Sodium 220Mg | 11 | 20.2 | 20.2 |
| Miconazole Nitrate | 5 | 14.2 | 14.2 |
| Etanercept | 202 | 10.6 | 10.6 |
| Agalsidase Beta | 3 | 8.0 | 8.0 |
| Diroximel Fumarate | 3 | 6.2 | 6.2 |